Few-Layer Graphene-Based Optical Nanobiosensors for the Early-Stage Detection of Ovarian Cancer Using Liquid Biopsy and an Active Learning Strategy
- 1Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
- 2Department of Electrical and Computer Engineering, Kansas State University, Manhattan, KS 66506, USA.
- 3Department of Obstetrics and Gynecology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
- 0Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Early ovarian cancer detection is crucial for survival. New graphene-based optical nanobiosensors (G-NBSs) accurately detect early-stage ovarian cancer using protease activity, achieving 94.5% accuracy.
Area Of Science
- Biomedical Engineering
- Nanotechnology
- Oncology
Background
- Ovarian cancer survival rates are significantly impacted by the stage at diagnosis.
- Early-stage detection is critical for improving patient outcomes and survival.
- Liquid biopsies offer a promising avenue for non-invasive early cancer detection.
Purpose Of The Study
- To develop and validate graphene-based optical nanobiosensors (G-NBSs) for early ovarian cancer detection.
- To quantify protease activities using a panel of G-NBSs for specific ovarian cancer identification.
- To implement a predictive model for early-stage ovarian cancer diagnosis.
Main Methods
- Development of few-layer explosion graphene nanobiosensors with hydrophilic coating.
- Utilizing fluorescently labeled consensus sequences for specific protease activity quantification.
- Employing a hierarchical framework with active learning (AL) for data analysis and prediction.
Main Results
- G-NBSs demonstrated statistically significant differences in protease activities between early-stage ovarian cancer, late-stage, and healthy controls.
- The active learning model achieved an overall accuracy of 94.5% for early-stage ovarian cancer detection.
- The system exhibited high sensitivity (0.94) and specificity (0.94) in distinguishing early-stage disease.
Conclusions
- Graphene-based optical nanobiosensors are effective tools for quantifying protease activities relevant to ovarian cancer.
- The developed G-NBSs panel and active learning framework show high potential for accurate and sensitive early-stage ovarian cancer detection.
- This approach represents a significant advancement in liquid biopsy technology for improving ovarian cancer diagnostics.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

